These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28425704)

  • 1. An ortho-Iminoquinone Compound Reacts with Lysine Inhibiting Aggregation while Remodeling Mature Amyloid Fibrils.
    Fernandes L; Moraes N; Sagrillo FS; Magalhães AV; de Moraes MC; Romão L; Kelly JW; Foguel D; Grimster NP; Palhano FL
    ACS Chem Neurosci; 2017 Aug; 8(8):1704-1712. PubMed ID: 28425704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for "Transfected" Parkinson's.
    Kabiraj P; Marin JE; Varela-Ramirez A; Narayan M
    ACS Chem Neurosci; 2016 Nov; 7(11):1519-1530. PubMed ID: 27635664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
    Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
    Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
    Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
    Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
    Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
    PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.
    Tsukakoshi K; Yoshida W; Kobayashi M; Kobayashi N; Kim J; Kaku T; Iguchi T; Nagasawa K; Asano R; Ikebukuro K; Sode K
    ACS Chem Neurosci; 2018 Dec; 9(12):2898-2903. PubMed ID: 30074759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins.
    Vaneyck J; Segers-Nolten I; Broersen K; Claessens MMAE
    J Biol Chem; 2021; 296():100358. PubMed ID: 33539920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemin as a generic and potent protein misfolding inhibitor.
    Liu Y; Carver JA; Ho LH; Elias AK; Musgrave IF; Pukala TL
    Biochem Biophys Res Commun; 2014 Nov; 454(2):295-300. PubMed ID: 25450392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.
    Bieschke J; Russ J; Friedrich RP; Ehrnhoefer DE; Wobst H; Neugebauer K; Wanker EE
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7710-5. PubMed ID: 20385841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pyrene-inhibitor fluorescent probe with large Stokes shift for the staining of Aβ
    Mahía A; Conde-Giménez M; Salillas S; Pallarés I; Galano-Frutos JJ; Lasa Í; Ventura S; Díaz-de-Villegas MD; Gálvez JA; Sancho J
    Anal Bioanal Chem; 2019 Jan; 411(1):251-265. PubMed ID: 30411148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases.
    Alam P; Chaturvedi SK; Siddiqi MK; Rajpoot RK; Ajmal MR; Zaman M; Khan RH
    Sci Rep; 2016 May; 6():26759. PubMed ID: 27230476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo designed protein inhibitors of amyloid aggregation and seeding.
    Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of
    Sternke-Hoffmann R; Peduzzo A; Bolakhrif N; Haas R; Buell AK
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-seeding effects of amyloid β-protein and α-synuclein.
    Ono K; Takahashi R; Ikeda T; Yamada M
    J Neurochem; 2012 Sep; 122(5):883-90. PubMed ID: 22734715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
    Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
    Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?
    Windisch M; Hutter-Paier B; Schreiner E; Wronski R
    J Mol Neurosci; 2004; 24(1):155-65. PubMed ID: 15314265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.